CompletedPhase 4ACTRN12611000569909

Oral Silodosin on Lower Urinary Tract Symptoms Due to Double-J stent: A Prospectively Randomized Study

Oral silodosin on lower urinary tract symptoms due to double-J stent

Sponsor

Chung Jing Wang

Enrollment

45 participants

Start Date

Nov 1, 2010

Study Type

Interventional

Conditions

urinary symptoms assosciated with indwelling double-J ureteral stents

Summary

a randomized double-blinded controlled study to evaluate the effect of silodosin in improving symptoms and quality of life in patients with indwelling double-J ureteral stents using specific questionnaire

Eligibility

Sex: Both males and femalesMin Age: 20 YearssMax Age: 60 Yearss

Plain Language Summary

Simplified for easier understanding

This study tests whether the oral medication silodosin can reduce urinary symptoms caused by a double-J ureteral stent placed after kidney stone removal. Participants aged 20 to 60 who had a stent placed after ureteroscopic stone removal may be eligible. Those with existing urinary conditions or alpha-blocker use are excluded.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

daily oral silodosin 4 mg for 2 weeks in improving symptoms and quality of life in patients with indwelling double-J ureteral stents using specific questionnaire

Locations(1)

Taiwan, Province Of China

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12611000569909